<DOC>
	<DOCNO>NCT02991677</DOCNO>
	<brief_summary>Chemotherapy-induced peripheral neuropathy ( CIPN ) continue serious healthcare concern . It painful , persistent , resistant conventional pain therapy , result long-term suffering decrease quality life many cancer survivor . The role exercise decrease CIPN-related neuropathic pain ( CIPN-NP ) investigate , goal identify mechanism associate therapeutic approach manage CIPN-NP .</brief_summary>
	<brief_title>Exercise Effect Chemotherapy-Induced Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Diagnosis cancer , stage IIV History treatment oxaliplatin , docetaxel , paclitaxel , either alone combination agent Completion chemotherapy &gt; 6 month &lt; 1 year Ability walk treadmill Medical clearance oncologist primary care provider Presence CIPN per National Cancer Institute Common Toxicity Criteria grade 13 ( 0no signs/symptoms , 1minor loss function , 2increased symptom interfere activity daily live ( ADLs ) , 3severe symptom interfere ADL , 4disabling , 5 death ) Score Neuropathic Pain Scale &gt; 1 Age 2170 Denial CIPN Other motor/sensory neuropathy cause chemotherapy ( i.e.alcoholrelated , autoimmune disease , diabetes ) Coronary artery disease History &gt; 1 chemotherapy regimen Musculoskeletal condition preclude participation exercise training program Pregnancy Regular exerciser , define &gt; 90 minute per week aerobic exercise resistive training</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>exercise</keyword>
	<keyword>neuropathy</keyword>
</DOC>